ProfileGDS4718 / 201430_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 29% 29% 68% 21% 24% 23% 32% 28% 30% 28% 25% 26% 30% 23% 30% 45% 32% 36% 31% 38% 29% 30% 25% 28% 18% 33% 25% 35% 27% 28% 43% 58% 33% 24% 52% 37% 25% 33% 25% 72% 23% 24% 71% 29% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.4881429
GSM549102patient 115, normal, homogenized [OPG study]4.5327729
GSM549104patient 119, normal, homogenized [OPG study]6.7639868
GSM549108patient 138, normal, homogenized [OPG study]4.2294621
GSM549119patient 077, normal, homogenized [OPG study]4.3205624
GSM549133patient 032, cancer, homogenized [OPG study]4.2253123
GSM549139patient 042, cancer, homogenized [OPG study]4.5918832
GSM549099patient 107, normal, homogenized [OPG study]4.497228
GSM549109patient 139, normal, homogenized [OPG study]4.5634230
GSM549110patient 046, normal, homogenized [OPG study]4.4692428
GSM549114patient 063, normal, homogenized [OPG study]4.3003525
GSM549122patient 082, normal, homogenized [OPG study]4.375226
GSM549134patient 033, cancer, homogenized [OPG study]4.5524530
GSM549136patient 036, cancer, homogenized [OPG study]4.2136923
GSM549140patient 044, cancer, homogenized [OPG study]4.4931130
GSM549111patient 047, normal, homogenized [OPG study]5.2090445
GSM549113patient 057, normal, homogenized [OPG study]4.5551232
GSM549132patient 031, cancer, homogenized [OPG study]4.7668736
GSM549137patient 038, cancer, homogenized [OPG study]4.5715831
GSM549142patient 047, cancer, homogenized [OPG study]5.0302938
GSM549100patient 110, normal, homogenized [OPG study]4.5331129
GSM549107patient 135, normal, homogenized [OPG study]4.5201630
GSM549115patient 068, normal, homogenized [OPG study]4.2971225
GSM549116patient 072, normal, homogenized [OPG study]4.4495528
GSM549120patient 078, normal, homogenized [OPG study]4.0748518
GSM549131patient 030, cancer, homogenized [OPG study]4.6215733
GSM549118patient 074, normal, homogenized [OPG study]4.3484225
GSM549129patient 027, cancer, homogenized [OPG study]4.7848235
GSM549123patient 088, normal, homogenized [OPG study]4.4222627
GSM549124patient 006, cancer, homogenized [OPG study]4.4853628
GSM549126patient 015, cancer, homogenized [OPG study]5.1321143
GSM549128patient 025, cancer, homogenized [OPG study]6.0312758
GSM549103patient 117, normal, homogenized [OPG study]4.7380633
GSM549117patient 073, normal, homogenized [OPG study]4.2921924
GSM549138patient 041, cancer, homogenized [OPG study]5.6183852
GSM549141patient 045, cancer, homogenized [OPG study]4.7923637
GSM549130patient 028, cancer, homogenized [OPG study]4.3516625
GSM549101patient 111, normal, homogenized [OPG study]4.6892933
GSM549105patient 128, normal, homogenized [OPG study]4.3456625
GSM549106patient 134, normal, homogenized [OPG study]7.126772
GSM549112patient 048, normal, homogenized [OPG study]4.2338123
GSM549125patient 011, cancer, homogenized [OPG study]4.2944524
GSM549127patient 024, cancer, homogenized [OPG study]7.0652171
GSM549135patient 035, cancer, homogenized [OPG study]4.4319429